Sep 22, 2023
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.09 to $0.90.
The split itself did not change the total investment value.
China Regenerative Medicine International Limited (HKEX:8158) operates in the Pharmaceuticals: major industry.
China Regenerative Medicine International Limited company overviewChina Regenerative Medicine International Limited's most recent stock split was on September 22, 2023. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
China Regenerative Medicine International Limited (HKEX:8158) has split its stock 3 times: a 4-for-1 split on August 29, 2007, a 1-for-20 reverse split on May 30, 2019, and a 1-for-10 reverse split on September 22, 2023.
China Regenerative Medicine International Limited has split its stock 3 times. This history records 3 splits between August 29, 2007 and September 22, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In China Regenerative Medicine International Limited's 1-for-10 reverse split on September 22, 2023, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
China Regenerative Medicine International Limited has not announced a new split in our records. Its most recent split was on September 22, 2023, 3 years ago. Companies announce splits in advance, and any new HKEX:8158 split will appear on this page.
Already premium?